10月17日，Oscar Health盘中下跌5.32%，报31.69美元，成交额1.17亿美元。
近期消息面上，最新研报指出，公司更新后的指引已反映积极的医疗利用率趋势，因此11月5日公布三季度业绩时，超预期空间或不如前期明显。
该机构同时将公司今明后年每股收益预期上调至2.00美元、2.30美元和2.80美元，但提示针对一大批会员的资格核查可能影响收入，若退保规模偏高，或侵蚀潜在上行空间；此前其目标价已由26美元上调至36美元，评级维持中性。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.